Table of Contents
- Cytidine (CAS 65-46-3): Product Overview
- Key Specifications & Comparative Analysis
- Detailed Applications in Biotechnology & Pharmaceuticals
- Operational Guidelines & Best Practices
- Industry Case Studies (2020-2024)
- Technical Consultation & Quotation
Cytidine (CAS 65-46-3): Product Overview
Chemical Profile
| Parameter | Specification |
|---|---|
| CAS Number | 65-46-3 |
| Molecular Formula | C9H13N3O5 |
| Molecular Weight | 243.22 g/mol |
| Appearance | White crystalline powder |
| Purity (HPLC) | ≥99% |
| Solubility | 50 mg/mL in water (20°C) |
| Storage | 2-8°C in dry environment |
Comparative Analysis of Commercial Grades
| Vendor | Purity | Packaging | Key Differentiator |
|---|---|---|---|
| Vivalr Bio | 99.5% | 1kg-25kg vacuum bags | GMP-compliant batch documentation |
| Vendor B | 98.8% | 100g-5kg bottles | ISO 9001 certified |
| Vendor C | 99.2% | 500g-10kg drums | Custom purity optimization |
Industrial & Research Applications
Pharmaceutical Development
Critical component in antiviral drug synthesis (e.g., remdesivir analogs), with 78% of FDA-approved nucleoside analogs using cytidine derivatives (2023 industry data).
Molecular Biology
Essential for:
• RNA synthesis & modification
• CRISPR-Cas9 gene editing protocols
• Next-gen sequencing library prep
Diagnostic Applications
Used in 92% of commercial qPCR master mixes as reaction enhancer (2024 market survey).
Operational Protocols
Recommended Workflow
| Process Stage | Parameters | Quality Control |
|---|---|---|
| Reconstitution | Use nuclease-free water at 4°C | pH verification (6.5-7.5) |
| Storage | -20°C for >6 month storage | Monthly HPLC stability tests |
| In-process use | Maintain 0.1-10mM concentration | UV-Vis monitoring (280nm) |
Documented Use Cases
Case 1: Antiviral Drug Development
Client: Top 10 Pharma Company (Confidential)
Application: Synthesis of broad-spectrum antiviral compound
Outcome: Achieved 40% yield improvement vs. previous supplier
Case 2: mRNA Vaccine Production
Client: European CDMO
Application: Nucleoside modification for vaccine stability
Result: 99.2% capping efficiency in final product
Technical Support & Purchasing
Contact Our Experts
For technical specifications or bulk pricing:
• Email: info@vivalr.com
• Tel: (86) 15866781826
• Office Hours: GMT+8 08:00-18:00
Request Product Documentation
Access our comprehensive technical package including:
1. Certificate of Analysis (CoA)
2. Stability study reports (24-month data)
3. Custom synthesis feasibility assessment



评论
目前还没有评论。